Abstract
The Canadian Paediatric Society endorses long-acting reversible contraception (LARC) methods as first line in the adolescent population ( 1). Previously, the only options on the Canadian market were intrauterine devices (IUDs), either copper or hormonal. The Nexplanon contraceptive implant is a new option for our patients, which is now available following Health Canada approval in 2020.

This publication has 7 references indexed in Scilit: